MiNA Therapeutics
PrivateLast Round
Corporate Funding
Jul 6, 2021
Est. Valuation
$176.56M
Total Funding Raised
$90.73M
Company Overview
MiNA Therapeutics is a biotechnology company that develops small activating RNA (saRNA) therapeutics to restore or enhance gene function for the treatment of cancer and severe genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MiNA Therapeutics Comparables
Compare MiNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ractigen Therapeutics | 85% | |
| CAMP4 | 79% | |
| Bristol Myers Squibb | 71% |
MiNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 6, 2021 | ||||
| Series A | Sep 10, 2020 | ||||
| Grant | Nov 2, 2017 | ||||
| Strategic | May 3, 2017 |
Key People
Founding team and executive leadership
MiNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| aMoon | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2025
New data from sickle cell disease program presented at EHA 2025 Congress.
- Jun 12, 2025
Presented at the European Hematology Association 2025 Congress.
MiNA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MiNA Therapeutics's valuation, stock price, and market status.
Is MiNA Therapeutics a public or private company?
MiNA Therapeutics is a private company.
What is the current stock price of MiNA Therapeutics?
MiNA Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is MiNA Therapeutics worth (valuation)?
MiNA Therapeutics's valuation is estimated at $176.6M based on funding round data.
Can I buy MiNA Therapeutics stock?
MiNA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MiNA Therapeutics's last funding round?
MiNA Therapeutics's most recent funding round was Series A Extension on May 3, 2017.
Who are the main investors in MiNA Therapeutics?
Key investors in MiNA Therapeutics include aMoon.
Will MiNA Therapeutics IPO soon?
No public IPO plans have been announced for MiNA Therapeutics.
How can I track MiNA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MiNA Therapeutics's secondary market activity and sign up for updates.